Eleven Therapeutics Recognized as One of the 50 Most Promising Startups in Israel
Read More
Eleven Therapeutics Announces $22 Million in Seed Funding
Read More
The virus mutates? We have the tools to fight back
Read More
Eleven Therapeutics receives a notice of award from Innovate UK Smart Grants
Read More
Eleven Therapeutics Appoints Prominent Biopharma Leader Dr. Iris Grossman as Chief Strategic Officer
Read More
Eleven Therapeutics Receives $3.9 Million for Development of Innovative Treatments Against Respiratory Viruses
Read More
Eleven Therapeutics Pursues Cooperative Research and Development (CRADA) with the National Institute of Allergy and Infectious Diseases in Fight Against Respiratory Viruses
Read More
